Submitted by Anonymous (not verified) on 21 September 2023 - 13:01
Human medicines European public assessment report (EPAR): Lynparza, olaparib, Ovarian Neoplasms, Date of authorisation: 16/12/2014, Revision: 23, Status: Authorised
Source: